Recently, some microRNAs has been proved to modulate FOXM1 expression in many cancers [10], including hepatocellular carcinoma [11], breast cancer [12], gastric cancer [13], colorectal cancer [14], bladder cancer [15], squamous cell carcinoma [16], lung cancer [17, 18], leukemia [19], etc. But little is known about the miRNAs-FOXM1 signaling pathways that modulate the pathogenesis and progression in cervical cancer patients. This evidence concerns the gene FOXM1 and urinary bladder carcinoma.